|
On December 23, 2022, Congress passed the NOPAIN Act (H.R. 3259/S. 586) - Non-Opioids Prevent Addiction in the Nation. This addressed outdated federal reimbursement policies that inadvertently incentivized prescribing opioids.
The NOPAIN Act will: • Expand patient and provider access to FDA approved non-opioid pain management approaches in all outpatient surgical settings beginning in 2025. • Require a report to Congress on limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for therapeutic services.
Click on the House or Senate bills above to learn more!
|